Filing Details
- Accession Number:
- 0001209191-18-012484
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-22 16:46:22
- Reporting Period:
- 2018-02-20
- Accepted Time:
- 2018-02-22 16:46:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202335 | W David Gryska | 1801 Augustine Cut-Off Wilmington DE 19803 | Executive Vice President, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-20 | 1,070 | $86.03 | 12,922 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-02-21 | 1,952 | $85.56 | 10,970 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares withheld to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Represents weighted average sale price. Actual sale prices ranged from $85.11 - $86.28.
- Includes an aggregate of 10,294 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Billionaire Hedge Funds
